Form D · Biotechnology
Gritstone bio, Inc.
Emeryville, CA · CIK 0001656634
Offering snapshot reported Nov 8, 2022 · SEC filing
- Reported sold
- $45M Offering amount: $45M
- Investors reported
- 6 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Oct 24, 2022 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Nov 8, 2022 | Initial | $44,999,992 | No comparison | 6 | SEC filing |
| Oct 22, 2021 | Initial | $55,000,000 | No comparison | 10 | SEC filing |
Offering details
- Securities
- Equity, Option to acquire, Security to be acquired
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $2.4M (estimated)
- Finders' fees
- $0 (estimated)
- Form D file number
- 021-464296
Includes the sale of (i) 6,637,165 shares of common stock ("Common Stock") at $2.26 per share and (ii) pre-funded warrants for 13,274,923 shares of Common Stock, at exercise price of $2.26 per share, with $2.2599 per share paid by each warrant purchaser.
Sales compensation recipients
Scroll to see all columns →
| Recipient | CRD | Associated broker-dealer |
|---|---|---|
| Evercore Group L.L.C. | 42405 | |
| Piper Sandler & Co. | 665 |
Source: Form D, filed Nov 8, 2022. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Shefali Agarwal | Director |
| Shefali Agarwal, M.D., M.P.H. | Director |
| Andrew Allen | Director, Executive |
| Andrew Allen, M.D., Ph.D. | Director, Executive |
| James Cho | Executive |
| Lawrence Corey | Director |
| Celia Economides | Executive |
| Vassiliki Economides | Executive |
| Clare Fisher | Director |
| Matt Hawryluk | Executive |
| Matthew Hawryluk | Executive |
| Richard Heyman, Ph.D. | Director |
| Elaine Jones | Director |
| Erin E. Jones | Executive |
| Elaine Jones, Ph.D. | Director |
| Karin Joos | Executive |
| Steve Krognes | Director |
| Judith Li | Director |
| Naiyer A. Rizvi | Director |
| Naiyer Rizvi, M.D. | Director |
| Rahsaan Thompson, J.D. | Executive |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
5959 Horton Street, Suite 300
Emeryville, CA, 94608
Emeryville, CA, 94608